Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?
about
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growthCNS aspergillosis: recognition, diagnosis and management.Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.Management of intracranial fungal infections in patients with haematological malignancies.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Reflections on the approach to treatment of a mycologic disaster.Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.Case Reports. Chronic and acute Aspergillus meningitis.Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.Pulmonary aspergillosis with possible cerebral involvement in a previously healthy pregnant woman.Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole.[Diagnostic imaging methods and therapy options for cerebral aspergillosis].Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.Recommendations for the treatment of established fungal infections
P2860
Q28279473-498E5FEF-E139-4E54-AF45-1F2B0BE75248Q31118905-B8D46B61-821B-4D9B-BCA5-552166FE8228Q33894472-BB27FD87-315B-4A07-8BB2-12FEC1F77F61Q33974722-14F35746-D75B-4025-B0BF-5B831448F181Q34474583-898AFA9A-CFB3-492B-8A77-A8B472E57BD2Q36286439-555ED865-A6E1-43CF-88A2-E657E71CC90EQ37041199-D2735CD9-52DC-46DD-B225-439A37CEEA14Q39767419-6FC1FB50-684B-47FA-800B-310AAFDAF584Q40388517-6B564D2D-2D19-4FD4-B697-1AD379013E9BQ43864353-E0E1A46E-74D5-418D-958E-3F3D5F16EB27Q44242735-B1C35DC2-FEC7-4404-BB86-6F6A1661A963Q44564506-63FF50ED-4EDE-4E94-89A7-286E8AD1AF61Q45257465-78CDCCB3-5E0A-45ED-A6DC-06984A6363E2Q46124302-AC434B32-E749-41CF-AE53-6B654C56F7F6Q52888501-B87243D2-5403-42AC-89DD-1BD47354CB60Q52926328-735BDD6A-C0D1-4067-A334-083D73E84644Q58207332-D8DC1A14-C756-4322-A5BC-7E9263A2CA68
P2860
Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Treatment of cerebral Aspergil ...... h doses improve the prognosis?
@en
type
label
Treatment of cerebral Aspergil ...... h doses improve the prognosis?
@en
prefLabel
Treatment of cerebral Aspergil ...... h doses improve the prognosis?
@en
P2093
P356
P1476
Treatment of cerebral Aspergil ...... h doses improve the prognosis?
@en
P2093
P304
P356
10.1093/CLINIDS/21.6.1485
P407
P577
1995-12-01T00:00:00Z